Atrys Health, S.A. logo

Atrys Health, S.A. (A2T)

Market Open
7 Aug, 20:00
XFRA XFRA
2. 48
-0
-0.2016%
223.65M Market Cap
- P/E Ratio
- Div Yield
3,076 Volume
- Eps
2.48
Previous Close
Add Transaction
Day Range
2.33 2.48
Year Range
2.06 3.39
Want to track A2T and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

A2T trading today lower at €2.48, a decrease of -0.2016% from yesterday's close, completing a monthly increase of 10.9865% or €0.25. Over the past 12 months, A2T stock lost -3.6965%.
A2T is not paying dividends to its shareholders.
The last earnings report, released on Apr 07, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Atrys Health, S.A. has completed 3 stock splits, with the recent split occurring on Sep 17, 2020.
The company's stock is traded on 5 different exchanges and in various currencies, with the primary listing on XMAD (EUR).

A2T Chart

People also search for

722
Antengene Corporation Limited
0.51
+10.7456%
7W3
Acotec Scientific Holdings Limited
0.83
+2.454%
Flerie AB (publ)
1.72
+0.2915%
R9Z
Immuneonco Biopharmaceutical Inc.
0.35
+6.0606%
25E
Elan Corporation plc
3.9
-1.0152%

Atrys Health, S.A. (A2T) FAQ

What is the stock price today?

The current price is €2.48.

On which exchange is it traded?

Atrys Health, S.A. is listed on XFRA.

What is its stock symbol?

The ticker symbol is A2T.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 223.65M.

Has Atrys Health, S.A. ever had a stock split?

Atrys Health, S.A. had 3 splits and the recent split was on Sep 17, 2020.

Atrys Health, S.A. Profile

Biotechnology Industry
Healthcare Sector
Ms. Isabel Lozano Fernandez CEO
XFRA Exchange
ES0105148003 ISIN
Spain Country
2,084 Employees
- Last Dividend
17 Sep 2020 Last Split
- IPO Date

Overview

Atrys Health, S.A., is a pioneering biomedical company based in Madrid, Spain, renowned for offering a broad spectrum of diagnostic services and innovative medical treatments. Established in 2007, the company initiated its operations under the name Althia Health, S.L., witnessing a significant rebranding in May 2016 to Atrys Health, S.A. Focused on integrating advanced technology in the healthcare sector, Atrys Health leverages telemedicine to enhance the accessibility and efficiency of healthcare services, spanning across various medical specialties including radiology, cardiology, ophthalmology, and dermatology. Atrys Health is committed to advancing medical research and clinical practices by developing new therapeutic modalities and diagnostic tools, thereby contributing to the improvement of global healthcare standards.

Products and Services

  • Diagnostic Services:

    Atrys Health specializes in a comprehensive range of diagnostic services aimed at facilitating early and precise disease detection. The company covers essential areas such as pathology, hematology, molecular pathology, and genetics, employing advanced methodologies to ensure accuracy and reliability.

  • Diagnostic Second Opinion:

    Recognizing the critical need for accuracy in diagnostics, Atrys Health offers diagnostic second opinion services. This initiative provides patients and healthcare professionals with an additional layer of analysis and verification for initial diagnostic findings, ensuring a higher degree of certainty in treatment planning.

  • Test Directory:

    To support comprehensive diagnostic evaluations, Atrys Health maintains an extensive test directory. This resource enables healthcare practitioners to access a wide array of tests, facilitating informed decision-making in patient care and treatment management.

  • Clinical Trials and R&D Services:

    At the forefront of clinical innovation, Atrys Health actively engages in clinical trials and research & development projects. These endeavors aim to explore and validate novel therapeutic approaches and diagnostic tools, contributing to the advancement of medical science and patient care.

  • Telemedicine Services:

    Atrys Health integrates telemedicine to offer expert medical consultations and services across several specialties, including radiology, cardiology, ophthalmology, and dermatology. This approach enables patients to receive high-quality care remotely, improving accessibility and convenience.

  • Radiotherapy:

    As part of its comprehensive treatment offerings, Atrys Health provides advanced radiotherapy services. This involves the use of high-energy radiation to treat cancer and other medical conditions, highlighting the company’s contribution to oncology.

  • Therapeutic Modalities and Diagnostic Tools Development:

    Atrys Health is dedicated to the development of new therapeutic modalities and diagnostic tools. Through innovative research and technological advancement, the company strives to enhance the efficacy and accuracy of medical treatments and diagnostics, paving the way for future healthcare innovations.

Contact Information

Address: Calle VelAzquez, 24
Phone: -